サマリー

神経学バイオマーカーの世界市場 2024-2028
神経学バイオマーカー市場は、2023〜2028年に78億2000万米ドルの成長が予測され、予測期間中のCAGRは13.01%で加速すると予測されています。当レポートでは、神経学的バイオマーカー市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。神経疾患の罹患率の上昇、神経疾患特異的バイオマーカーの臨床試験の増加、神経医療へのアクセスを改善するための政府による取り組みや支援の増加が市場を牽引しています。
Technavioの神経疾患バイオマーカー市場は以下のようにセグメント化されています：
エンドユーザー別
- 病院
- 臨床診断センター
- 研究機関、その他
適応症別
- AD
- PD
- ASD
- MS
- その他
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、正確な神経学的診断への注目が高まっていることが、今後数年間における神経学的バイオマーカー市場の成長を促進する主な理由の1つであるとしている。また、血液ベースのバイオマーカーの利用可能性の高まりと手動のmiRNAの進化は、市場の大きな需要につながる。
神経学的バイオマーカー市場に関するレポートは以下の分野をカバーしています：
- 神経学バイオマーカー市場規模
- 神経学バイオマーカー市場予測
- 神経学的バイオマーカー市場の業界分析
本レポートでは、神経学的バイオマーカー市場の主要ベンダーであるAbbott Laboratories社、ACROBIOSYSTEMS INC.社、Advanced Brain Monitoring Inc.社、Alseres Pharmaceuticals Inc.社、Bio Rad Laboratories Inc、bioMerieux SA、Charles River Laboratories International Inc.、EATRIS ERIC、Eli Lilly and Co.、Enzo Biochem Inc.、F. Hoffmann La Roche Ltd.、Fujirebio Holdings Inc.、IQVIA Holdings Inc.、Merck KGaA、Metabolon Inc.、PerkinElmer Inc.、Proteome Sciences plc、QIAGEN NV、Quanterix Corp.、Thermo Fisher Scientific Inc.などです。また、神経バイオマーカー市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/neurological-biomarkers-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global neurological biomarkers market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global neurological biomarkers market 2018 - 2022 ($ billion)
o 4.2 End-user Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
o 4.3 Indication Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Indication Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospitals - Market size and forecast 2023-2028
o Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
o 6.4 Clinical diagnostic centers - Market size and forecast 2023-2028
o Exhibit 38: Chart on Clinical diagnostic centers - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Clinical diagnostic centers - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Clinical diagnostic centers - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Clinical diagnostic centers - Year-over-year growth 2023-2028 (%)
o 6.5 Research organizations and others - Market size and forecast 2023-2028
o Exhibit 42: Chart on Research organizations and others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Research organizations and others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Research organizations and others - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Research organizations and others - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ billion)
o Exhibit 47: Data Table on Market opportunity by End-user ($ billion)
• 7 Market Segmentation by Indication
o 7.1 Market segments
o Exhibit 48: Chart on Indication - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Indication - Market share 2023-2028 (%)
o 7.2 Comparison by Indication
o Exhibit 50: Chart on Comparison by Indication
o Exhibit 51: Data Table on Comparison by Indication
o 7.3 AD - Market size and forecast 2023-2028
o Exhibit 52: Chart on AD - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on AD - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on AD - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on AD - Year-over-year growth 2023-2028 (%)
o 7.4 PD - Market size and forecast 2023-2028
o Exhibit 56: Chart on PD - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on PD - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on PD - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on PD - Year-over-year growth 2023-2028 (%)
o 7.5 ASD - Market size and forecast 2023-2028
o Exhibit 60: Chart on ASD - Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on ASD - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on ASD - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on ASD - Year-over-year growth 2023-2028 (%)
o 7.6 MS - Market size and forecast 2023-2028
o Exhibit 64: Chart on MS - Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Data Table on MS - Market size and forecast 2023-2028 ($ billion)
o Exhibit 66: Chart on MS - Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on MS - Year-over-year growth 2023-2028 (%)
o 7.7 Others - Market size and forecast 2023-2028
o Exhibit 68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 70: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 71: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 7.8 Market opportunity by Indication
o Exhibit 72: Market opportunity by Indication ($ billion)
o Exhibit 73: Data Table on Market opportunity by Indication ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 77: Chart on Geographic comparison
o Exhibit 78: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 UK - Market size and forecast 2023-2028
o Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.10 China - Market size and forecast 2023-2028
o Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.11 France - Market size and forecast 2023-2028
o Exhibit 111: Chart on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 112: Data Table on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 113: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 114: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 117: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 119: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 120: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 121: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 122: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 123: Abbott Laboratories - Overview
o Exhibit 124: Abbott Laboratories - Business segments
o Exhibit 125: Abbott Laboratories - Key news
o Exhibit 126: Abbott Laboratories - Key offerings
o Exhibit 127: Abbott Laboratories - Segment focus
o 12.4 ACROBIOSYSTEMS INC.
o Exhibit 128: ACROBIOSYSTEMS INC. - Overview
o Exhibit 129: ACROBIOSYSTEMS INC. - Product / Service
o Exhibit 130: ACROBIOSYSTEMS INC. - Key offerings
o 12.5 Alseres Pharmaceuticals Inc
o Exhibit 131: Alseres Pharmaceuticals Inc - Overview
o Exhibit 132: Alseres Pharmaceuticals Inc - Product / Service
o Exhibit 133: Alseres Pharmaceuticals Inc - Key offerings
o 12.6 Bio Rad Laboratories Inc.
o Exhibit 134: Bio Rad Laboratories Inc. - Overview
o Exhibit 135: Bio Rad Laboratories Inc. - Business segments
o Exhibit 136: Bio Rad Laboratories Inc. - Key news
o Exhibit 137: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 138: Bio Rad Laboratories Inc. - Segment focus
o 12.7 bioMerieux SA
o Exhibit 139: bioMerieux SA - Overview
o Exhibit 140: bioMerieux SA - Product / Service
o Exhibit 141: bioMerieux SA - Key news
o Exhibit 142: bioMerieux SA - Key offerings
o 12.8 Eli Lilly and Co.
o Exhibit 143: Eli Lilly and Co. - Overview
o Exhibit 144: Eli Lilly and Co. - Product / Service
o Exhibit 145: Eli Lilly and Co. - Key news
o Exhibit 146: Eli Lilly and Co. - Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 147: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 148: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 149: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 150: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 151: F. Hoffmann La Roche Ltd. - Segment focus
o 12.10 IQVIA Holdings Inc.
o Exhibit 152: IQVIA Holdings Inc. - Overview
o Exhibit 153: IQVIA Holdings Inc. - Business segments
o Exhibit 154: IQVIA Holdings Inc. - Key news
o Exhibit 155: IQVIA Holdings Inc. - Key offerings
o Exhibit 156: IQVIA Holdings Inc. - Segment focus
o 12.11 Merck KGaA
o Exhibit 157: Merck KGaA - Overview
o Exhibit 158: Merck KGaA - Business segments
o Exhibit 159: Merck KGaA - Key news
o Exhibit 160: Merck KGaA - Key offerings
o Exhibit 161: Merck KGaA - Segment focus
o 12.12 Metabolon Inc.
o Exhibit 162: Metabolon Inc. - Overview
o Exhibit 163: Metabolon Inc. - Product / Service
o Exhibit 164: Metabolon Inc. - Key offerings
o 12.13 PerkinElmer Inc
o Exhibit 165: PerkinElmer Inc - Overview
o Exhibit 166: PerkinElmer Inc - Business segments
o Exhibit 167: PerkinElmer Inc - Key news
o Exhibit 168: PerkinElmer Inc - Key offerings
o Exhibit 169: PerkinElmer Inc - Segment focus
o 12.14 Proteome Sciences plc
o Exhibit 170: Proteome Sciences plc - Overview
o Exhibit 171: Proteome Sciences plc - Product / Service
o Exhibit 172: Proteome Sciences plc - Key offerings
o 12.15 QIAGEN NV
o Exhibit 173: QIAGEN NV - Overview
o Exhibit 174: QIAGEN NV - Product / Service
o Exhibit 175: QIAGEN NV - Key news
o Exhibit 176: QIAGEN NV - Key offerings
o 12.16 Quanterix Corp.
o Exhibit 177: Quanterix Corp. - Overview
o Exhibit 178: Quanterix Corp. - Product / Service
o Exhibit 179: Quanterix Corp. - Key offerings
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 180: Thermo Fisher Scientific Inc. - Overview
o Exhibit 181: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 182: Thermo Fisher Scientific Inc. - Key news
o Exhibit 183: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 184: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 185: Inclusions checklist
o Exhibit 186: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 187: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 188: Research methodology
o Exhibit 189: Validation techniques employed for market sizing
o Exhibit 190: Information sources
o 13.5 List of abbreviations
o Exhibit 191: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global neurological biomarkers market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Indication Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on End-user - Market share 2023-2028 (%)
Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Clinical diagnostic centers - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Clinical diagnostic centers - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Clinical diagnostic centers - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Clinical diagnostic centers - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Research organizations and others - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Research organizations and others - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Research organizations and others - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Research organizations and others - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by End-user ($ billion)
Exhibits47: Data Table on Market opportunity by End-user ($ billion)
Exhibits48: Chart on Indication - Market share 2023-2028 (%)
Exhibits49: Data Table on Indication - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Indication
Exhibits51: Data Table on Comparison by Indication
Exhibits52: Chart on AD - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on AD - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on AD - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on AD - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on PD - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on PD - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on PD - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on PD - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on ASD - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on ASD - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on ASD - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on ASD - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on MS - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on MS - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on MS - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on MS - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by Indication ($ billion)
Exhibits73: Data Table on Market opportunity by Indication ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ billion)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Abbott Laboratories - Overview
Exhibits124: Abbott Laboratories - Business segments
Exhibits125: Abbott Laboratories - Key news
Exhibits126: Abbott Laboratories - Key offerings
Exhibits127: Abbott Laboratories - Segment focus
Exhibits128: ACROBIOSYSTEMS INC. - Overview
Exhibits129: ACROBIOSYSTEMS INC. - Product / Service
Exhibits130: ACROBIOSYSTEMS INC. - Key offerings
Exhibits131: Alseres Pharmaceuticals Inc - Overview
Exhibits132: Alseres Pharmaceuticals Inc - Product / Service
Exhibits133: Alseres Pharmaceuticals Inc - Key offerings
Exhibits134: Bio Rad Laboratories Inc. - Overview
Exhibits135: Bio Rad Laboratories Inc. - Business segments
Exhibits136: Bio Rad Laboratories Inc. - Key news
Exhibits137: Bio Rad Laboratories Inc. - Key offerings
Exhibits138: Bio Rad Laboratories Inc. - Segment focus
Exhibits139: bioMerieux SA - Overview
Exhibits140: bioMerieux SA - Product / Service
Exhibits141: bioMerieux SA - Key news
Exhibits142: bioMerieux SA - Key offerings
Exhibits143: Eli Lilly and Co. - Overview
Exhibits144: Eli Lilly and Co. - Product / Service
Exhibits145: Eli Lilly and Co. - Key news
Exhibits146: Eli Lilly and Co. - Key offerings
Exhibits147: F. Hoffmann La Roche Ltd. - Overview
Exhibits148: F. Hoffmann La Roche Ltd. - Business segments
Exhibits149: F. Hoffmann La Roche Ltd. - Key news
Exhibits150: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits151: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits152: IQVIA Holdings Inc. - Overview
Exhibits153: IQVIA Holdings Inc. - Business segments
Exhibits154: IQVIA Holdings Inc. - Key news
Exhibits155: IQVIA Holdings Inc. - Key offerings
Exhibits156: IQVIA Holdings Inc. - Segment focus
Exhibits157: Merck KGaA - Overview
Exhibits158: Merck KGaA - Business segments
Exhibits159: Merck KGaA - Key news
Exhibits160: Merck KGaA - Key offerings
Exhibits161: Merck KGaA - Segment focus
Exhibits162: Metabolon Inc. - Overview
Exhibits163: Metabolon Inc. - Product / Service
Exhibits164: Metabolon Inc. - Key offerings
Exhibits165: PerkinElmer Inc - Overview
Exhibits166: PerkinElmer Inc - Business segments
Exhibits167: PerkinElmer Inc - Key news
Exhibits168: PerkinElmer Inc - Key offerings
Exhibits169: PerkinElmer Inc - Segment focus
Exhibits170: Proteome Sciences plc - Overview
Exhibits171: Proteome Sciences plc - Product / Service
Exhibits172: Proteome Sciences plc - Key offerings
Exhibits173: QIAGEN NV - Overview
Exhibits174: QIAGEN NV - Product / Service
Exhibits175: QIAGEN NV - Key news
Exhibits176: QIAGEN NV - Key offerings
Exhibits177: Quanterix Corp. - Overview
Exhibits178: Quanterix Corp. - Product / Service
Exhibits179: Quanterix Corp. - Key offerings
Exhibits180: Thermo Fisher Scientific Inc. - Overview
Exhibits181: Thermo Fisher Scientific Inc. - Business segments
Exhibits182: Thermo Fisher Scientific Inc. - Key news
Exhibits183: Thermo Fisher Scientific Inc. - Key offerings
Exhibits184: Thermo Fisher Scientific Inc. - Segment focus
Exhibits185: Inclusions checklist
Exhibits186: Exclusions checklist
Exhibits187: Currency conversion rates for US$
Exhibits188: Research methodology
Exhibits189: Validation techniques employed for market sizing
Exhibits190: Information sources
Exhibits191: List of abbreviations